KAIST Develops IoT Microneedle Device for Remote Pain Management
A new wearable electroceutical platform uses conductive microneedles and real-time stress monitoring to provide a non-pharmacological alternative to opioids.
Researchers from KAIST and the Korea Institute of Oriental Medicine (KIOM) have developed a wireless, IoT-enabled wearable electroceutical device for personalized pain management. The platform utilizes conductive microneedles to deliver stable electrical stimulation through the skin, offering a minimally invasive alternative to systemic painkillers or surgical implants.
The device employs temperature-responsive, conductive, and adhesive microneedles coated with a conductive hydrogel. According to research published in Nature Communications, this design ensures even current distribution and reduces the risk of skin burns. To automate treatment, the platform integrates a photoplethysmography (PPG) sensor that detects pain-related physiological stress, triggering electrical stimulation automatically via a closed-loop therapy mode. The system is also compatible with smartphone remote control; researchers verified this capability by testing the device across international distances between Korea and the United States.
The Shift from Systemic Treatment
Chronic pain management has traditionally relied on oral analgesics or opioids, which frequently lead to systemic side effects, chemical dependency, and increased tolerance over time. While electroceuticals—devices that use electrical stimulation to modulate nerve activity—exist, they are often impractical for daily use. Current options are typically either invasive, requiring surgical implantation, or inefficient, as standard skin-attached electrodes are often hindered by sweat and dead skin cells, which impede electrical conductivity.
Implications for Digital Healthcare
This technology represents a potential shift from hospital-centric care toward personalized, home-based digital healthcare. By combining neuromodulation with the Internet of Things (IoT) and real-time physiological monitoring, the platform reduces medical reliance on opioids and enables precise, remote supervision by healthcare providers. Professor Jae-Woong Jeong of the KAIST School of Electrical Engineering noted that combining a stable skin interface with IoT-based remote management expands the potential for wearable electroceuticals in daily life.
Future Integration
Looking ahead, the researchers aim to merge this platform with other specialized treatments. Dr. Sanghun Lee of KIOM stated that the goal is to integrate this research with future wearable acupuncture technologies. This would allow for a non-pharmacological approach that specifically stimulates acupoints through electrical stimulation, further refining the precision of connected pain therapy. By bridging the gap between traditional acupuncture and modern IoT connectivity, the team hopes to create a scalable ecosystem for chronic pain relief that operates independently of pharmaceutical intervention.